Pituitary & hypothalamus

GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency

J Clin Endocrinol MetabPublished Cohort study

Authors' conclusion

The GST provides valuable insights into GH deficiency in transitional-age patients with CO-GHD. GH response is primarily influenced by the severity of pituitary dysfunction, with BMI playing a minimal role once adjusted for etiology.

Study context

Population
Transitional-age patients with childhood-onset GH deficiency (GHD) (median age 17.39 years) undergoing glucagon stimulation test (GST); childhood cancer survivors 42%
Participants
180 patients
Exposure
GH response to GST by etiology and body mass index (BMI) category
  • Isolated GHDn = 80
  • Organic moderate GHDn = 63
  • Organic severe GHDn = 37
Outcome
Peak GH response to GST

Main finding

As reported in the abstract

Significant inverse association with severity of pituitary dysfunction
P < .001
Inverse correlation with BMI SD score
ρ = −0.46, P < .001

Observational data: associations, not effects.

Further findings

Peak GH stratified by etiology or childhood cancer survivors (CCS) status

GH peaks primarily influenced by hypothalamic-pituitary damage, BMI showing a minimal effect

Original publication

GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency. J Clin Endocrinol Metab. Published 12 January 2026. doi:10.1210/clinem/dgaf674

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.